JPS56169671A - Substituted phenoxyacetic acid cyclic amine compound, its manufacture and metabolism regulant containing it as major component - Google Patents

Substituted phenoxyacetic acid cyclic amine compound, its manufacture and metabolism regulant containing it as major component

Info

Publication number
JPS56169671A
JPS56169671A JP6616581A JP6616581A JPS56169671A JP S56169671 A JPS56169671 A JP S56169671A JP 6616581 A JP6616581 A JP 6616581A JP 6616581 A JP6616581 A JP 6616581A JP S56169671 A JPS56169671 A JP S56169671A
Authority
JP
Japan
Prior art keywords
metabolism
manufacture
amine compound
major component
cyclic amine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP6616581A
Other languages
English (en)
Inventor
Godofurowa Jiyannjiyatsuku
Chiyuiie Jiyan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bpifrance Financement SA
Original Assignee
Agence National de Valorisation de la Recherche ANVAR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agence National de Valorisation de la Recherche ANVAR filed Critical Agence National de Valorisation de la Recherche ANVAR
Publication of JPS56169671A publication Critical patent/JPS56169671A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Obesity (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP6616581A 1980-04-30 1981-04-30 Substituted phenoxyacetic acid cyclic amine compound, its manufacture and metabolism regulant containing it as major component Pending JPS56169671A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8009885A FR2481702A1 (fr) 1980-04-30 1980-04-30 Phenoxyacetates substitues d'amines cycliques, procede d'obtention, applications a titre de medicaments et compositions pharmaceutiques les contenant

Publications (1)

Publication Number Publication Date
JPS56169671A true JPS56169671A (en) 1981-12-26

Family

ID=9241573

Family Applications (1)

Application Number Title Priority Date Filing Date
JP6616581A Pending JPS56169671A (en) 1980-04-30 1981-04-30 Substituted phenoxyacetic acid cyclic amine compound, its manufacture and metabolism regulant containing it as major component

Country Status (7)

Country Link
US (1) US4425352A (ja)
EP (1) EP0039636B1 (ja)
JP (1) JPS56169671A (ja)
AT (1) ATE9091T1 (ja)
DE (1) DE3165641D1 (ja)
ES (1) ES501743A0 (ja)
FR (1) FR2481702A1 (ja)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL250478A (ja) 1959-04-15
GB886437A (en) * 1959-07-15 1962-01-10 Beecham Res Lab Improvements in or relating to basic esters of etherified benzilic acids
US3448110A (en) * 1966-10-03 1969-06-03 Sandoz Ag Derivatives of isobutyric acid
GB1209750A (en) * 1967-05-09 1970-10-21 Rech S Et D Applic Scient Et M Improvements in or relating to 2,2,6,6,-tetramethyl piperidine and 1,2,3,6,-tetrahydro-2,2,6,6-tetramethyl pyridine derivatives
US4233298A (en) 1969-01-31 1980-11-11 Orchimed Sa Esters of p-carbonylphenoxy-isobutyric acids
US3708587A (en) * 1970-06-08 1973-01-02 Ciba Geigy Corp Hypocholesterolemic phenoxy-aliphatic acid compositions
US3683086A (en) * 1970-07-13 1972-08-08 Sandoz Ag Derivatives of acetic acid for the alleviation of hyperlipemia
US3755417A (en) * 1971-10-04 1973-08-28 American Home Prod Tris (4-chlorophenoxy)acetic acid and esters thereof
DE2358789A1 (de) * 1973-02-07 1975-06-05 Merck Patent Gmbh Hydratropasaeure-derivate und verfahren zu ihrer herstellung
NL7416412A (nl) * 1973-12-27 1975-07-01 Siegfried Ag Werkwijze ter bereiding van nieuwe cholesterol- gende verbindingen.

Also Published As

Publication number Publication date
FR2481702A1 (fr) 1981-11-06
EP0039636B1 (fr) 1984-08-22
EP0039636A1 (fr) 1981-11-11
ES8202797A1 (es) 1982-03-01
DE3165641D1 (en) 1984-09-27
ATE9091T1 (de) 1984-09-15
FR2481702B1 (ja) 1983-05-27
ES501743A0 (es) 1982-03-01
US4425352A (en) 1984-01-10

Similar Documents

Publication Publication Date Title
FI893467A0 (fi) Menetelmä lääkeaineena käyttökelpoisten 4-oksokinoliini-3-karboksyylihapon johdannaisten valmistamiseksi
MY100040A (en) Substituted azabicyclo compounds.
ATE47138T1 (de) Verfahren zur herstellung von 1,2-dithiolan-3pentans|ure (thioctsaeure).
PT83992A (de) Verfahren zur herstellung von unsymmetrischen thioethern
GR3034023T3 (en) Phenyl carboxamide-isoxazole-derivatives and salts, process for their preparation, their use as pharmaceuticals, and pharmaceutical compositions containing them.
TW328948B (en) Composition and process for the synthesis of oxysulphide-containing fluorine-containing organic derivatives
GR3030234T3 (en) 4-Phenylcarbamoyl-3-isoxazolecarboxylic acid derivatives with antiinflammatory activity
ES2001697A6 (es) Procedimiento para preparar 2-aminopurinas sustituidas en posiciones 6 y 9
JPS56169671A (en) Substituted phenoxyacetic acid cyclic amine compound, its manufacture and metabolism regulant containing it as major component
ATE100077T1 (de) 2-hydroxy-3-phenoxypropylaminoverbindungen.
DE3889772D1 (de) Verfahren zur Herstellung von 3,3-Diarylacrylsäureamiden.
HUT37935A (en) Process for production of 3-alkoxi-2-n-pirrolidin-n-piridil-n-furil /or n-tienil/-methil-prophil amins
SE8205256L (sv) Tricykliska kinazolinoner
ZA868019B (en) Heterocyclic amino compounds
DK60793D0 (da) Kemiske forbindelser, deres fremstilling og anvendelse
GB1545077A (en) Process for purifying water using bis-isothiouronium salts
IT1173206B (it) Procedimento per la preparazione di n-(dibenzilossifosforil) cianammide,composto cosi' ottenuto,processi che utilizzano detto composto quale intermedio di sintesi di sostanze fosfagene e sostanze in tal modo prodotte
ATE59040T1 (de) Verfahren zur herstellung von ergolinylthioharnstoffen.
EP0242950A3 (en) Dihydropyridines, process for their preparation and their use as therapeutics
ES8802568A1 (es) Un procedimiento para preparar nuevos anologos del acido araquidonico.
ATE42089T1 (de) Verfahren zur herstellung von bromfluoressigs|ure.